Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03447249
Brief Title: A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)

First Submitted : February 21, 2018
First Submitted that Met QC Criteria : February 21, 2018
First Posted : February 27, 2018

Results First Submitted : February 5, 2020
Results First Submitted that Met QC Criteria : March 12, 2020
Results First Posted : March 13, 2020

Last Update Submitted that Met QC Criteria : March 12, 2020
Last Update Posted : March 13, 2020